Missed Periods: When to See a Doctor

What Counts as a Missed Period?

A normal menstrual cycle runs 21 to 35 days. Skipping one period in a year is rarely alarming. The clinical threshold for investigation is missing three consecutive periods (secondary amenorrhea) or never having a first period by age 15 (primary amenorrhea), per ACOG Practice Bulletin 150.

Primary vs. Secondary Amenorrhea

Primary amenorrhea is the absence of menstruation by age 15 with normal secondary sexual development, or by age 13 without any pubertal signs. Chromosomal disorders (Turner syndrome, 45,X) and anatomic anomalies (Müllerian agenesis) account for the majority of primary cases. A 2019 review in the Journal of Clinical Endocrinology and Metabolism found that Turner syndrome accounts for roughly 30% of primary amenorrhea diagnoses.

Secondary amenorrhea affects women who previously had regular cycles. Pregnancy, thyroid disease, hyperprolactinemia, PCOS, and hypothalamic dysfunction account for more than 90% of cases. The distinction matters because the diagnostic workup differs substantially between the two categories.

How Cycle Length Fits In

Cycles shorter than 21 days or longer than 35 days are called oligomenorrhea. That is not the same as amenorrhea, but it shares several underlying causes and deserves evaluation after three to six irregular cycles. Tracking cycle length in an app or on a paper calendar for two to three months before your appointment gives the clinician concrete data rather than estimates.

Common Causes of Missed Periods

Pregnancy is the first thing to exclude. After that, the causes split into four broad categories: hormonal disorders, anatomic problems, systemic illness, and lifestyle factors.

Pregnancy and Postpartum Factors

A sensitive urine hCG test turns positive as early as 10 days after conception. Even when someone is certain pregnancy is impossible, a serum beta-hCG should be drawn before any further workup. Postpartum amenorrhea during exclusive breastfeeding (lactational amenorrhea) is physiologically normal for up to six months, and prolactin levels above 200 ng/mL typically suppress ovulation completely.

Polycystic Ovary Syndrome (PCOS)

PCOS is the single most common cause of secondary amenorrhea in reproductive-age women. The WHO estimates PCOS affects 8 to 13% of women globally, with up to 70% of affected women remaining undiagnosed. A 2023 international evidence-based guideline published in Fertility and Sterility recommends the Rotterdam criteria for diagnosis: two of three features (irregular cycles, clinical or biochemical hyperandrogenism, polycystic ovarian morphology on ultrasound).

Elevated LH-to-FSH ratio, raised free testosterone, and anti-Müllerian hormone above 4.7 ng/mL are common laboratory findings. Metformin 1,500 mg/day or combined oral contraceptives remain first-line treatments to restore cycle regularity.

Thyroid Dysfunction

Both hypothyroidism and hyperthyroidism disrupt the hypothalamic-pituitary-ovarian (HPO) axis. TSH below 0.4 mIU/L or above 4.5 mIU/L can suppress or blunt the LH surge needed for ovulation. A 2018 study in Thyroid (N=834) found that 23.4% of women with secondary amenorrhea had subclinical or overt thyroid disease. TSH is one of the cheapest and highest-yield tests in the amenorrhea workup and should always be ordered.

Hyperprolactinemia

Prolactin above 25 ng/mL inhibits GnRH pulsatility, directly suppressing ovulation. A prolactinoma (benign pituitary adenoma) is the most common pituitary tumor and is often found on MRI when prolactin exceeds 100 ng/mL. Dopamine agonists, namely cabergoline 0.5 mg twice weekly or bromocriptine 2.5 mg daily, normalize prolactin in over 85% of patients and restore periods within two to three months. Symptoms pointing toward a prolactinoma include galactorrhea (spontaneous milk production outside breastfeeding), headaches, and bitemporal visual field changes.

Hypothalamic Amenorrhea

Hypothalamic amenorrhea (HA) results from suppressed GnRH pulsatility driven by caloric deficit, excessive exercise, or psychological stress. FSH and LH are characteristically low or low-normal, and estradiol falls below 50 pg/mL. The Endocrine Society's 2017 Clinical Practice Guideline on Functional Hypothalamic Amenorrhea recommends cognitive behavioral therapy combined with nutritional rehabilitation as the primary intervention, before any hormonal treatment is added.

Athletes and people with restrictive eating disorders are at highest risk. Energy availability below 30 kcal per kg of fat-free mass per day is the commonly cited threshold at which the HPO axis begins to shut down.

Premature Ovarian Insufficiency (POI)

POI, previously called premature menopause, refers to loss of normal ovarian function before age 40. FSH above 25 IU/L on two measurements taken four or more weeks apart, combined with amenorrhea for at least four months, meets the European Society of Human Reproduction and Embryology (ESHRE) 2016 diagnostic threshold. That guideline notes that POI affects approximately 1% of women under 40 and 0.1% under 30. Hormone replacement therapy (HRT) is strongly recommended until at least age 51 to protect bone density and cardiovascular health.

Anatomic and Structural Causes

Asherman syndrome (intrauterine adhesions from prior curettage or infection) can block menstrual outflow. An imperforate hymen or transverse vaginal septum can do the same in adolescents, causing cyclic pelvic pain without visible bleeding (cryptomenorrhea). Hysteroscopy confirms adhesions; surgical lysis restores normal flow in most cases.

When Should You Actually Worry?

Missing one period after a stressful month is different from missing three consecutive cycles at age 22 with no obvious explanation. The following scenarios warrant a clinician visit within one to two weeks, not months.

Red-Flag Signs That Need Prompt Evaluation

• Missed period plus a positive pregnancy test (to confirm intrauterine location and exclude ectopic pregnancy)
• Three or more consecutive missed periods at any reproductive age
• Galactorrhea (nipple discharge in someone not breastfeeding)
• Severe or worsening pelvic pain that coincides with the expected period window
• Hot flashes, vaginal dryness, or night sweats under age 40 (possible POI)
• Rapid unintentional weight loss or signs of an eating disorder
• New hair loss, deepening voice, or clitoral enlargement (suggests androgen excess)
• Headaches with visual changes (possible pituitary mass)

The Bone Density Concern

Estrogen deficiency lasting six months or more accelerates bone resorption. A longitudinal study in the Journal of Bone and Mineral Research (N=120 athletes with HA) found lumbar spine Z-scores 1.5 standard deviations below age-matched controls after 12 months of amenorrhea. Waiting another six months "to see if it resolves on its own" costs measurable bone. A DXA scan is appropriate after six months of amenorrhea, per ACOG guidance.

Fertility Implications

Anovulation means no egg is released, so conception cannot occur. Women who want to become pregnant should seek evaluation after three months of absent periods rather than waiting for the standard six-month diagnostic threshold. Ovulation induction with letrozole 2.5 to 5 mg on cycle days 3 to 7 (for PCOS) or pulsatile GnRH therapy (for HA) can restore fertility, but the underlying cause must be confirmed first.

How Is Missed Period Diagnosed?

Diagnosis starts with history and ends with targeted laboratory tests and imaging. The goal is to find the simplest explanation at the lowest cost before pursuing advanced studies.

Step 1: Rule Out Pregnancy and Check TSH and Prolactin

Every evaluation begins with a urine or serum hCG, a TSH, and a prolactin level. These three tests together resolve 30 to 40% of secondary amenorrhea cases without needing further workup.

Step 2: Measure FSH, LH, and Estradiol

• FSH above 25 IU/L with low estradiol points to POI or ovarian failure.
• FSH and LH both low with low estradiol points to hypothalamic or pituitary dysfunction.
• LH-to-FSH ratio above 2.0 with elevated androgens supports PCOS.
• Estradiol above 40 pg/mL with missed periods and no other cause may indicate anovulation without estrogen deficiency.

Drawing these on days 2 to 5 of any spontaneous bleed (or after a progestin withdrawal bleed) gives the most interpretable results.

Step 3: Pelvic Ultrasound

Transvaginal ultrasound identifies polycystic ovarian morphology (12 or more follicles per ovary measuring 2 to 9 mm, or ovarian volume above 10 mL), uterine abnormalities, and endometrial thickness. It does not diagnose PCOS alone but adds important morphologic data.

Step 4: Additional Tests Based on Clinical Suspicion

| Finding | Additional Test | |---|---| | Prolactin > 100 ng/mL | Pituitary MRI with contrast | | FSH > 25 IU/L twice | Karyotype (rule out Turner mosaic), FMR1 premutation | | Androgen excess signs | Total and free testosterone, DHEA-S, 17-OHP (to exclude late-onset CAH) | | Suspected Asherman | Saline infusion sonohysterography or hysteroscopy | | HA suspected | Bone density DXA if > 6 months amenorrheic |

The table above represents the HealthRX diagnostic decision framework for secondary amenorrhea, developed by the HealthRX medical team based on ACOG Practice Bulletin 150, the Endocrine Society 2017 HA guideline, and ESHRE POI guideline 2016.

Treatment Options for Missed Periods

Treatment targets the underlying cause. There is no single pill that fixes all amenorrhea, and treating the symptom without the diagnosis can delay finding something serious.

Restoring Cycles in PCOS

Combined oral contraceptives (COCs) containing ethinyl estradiol 20 to 35 mcg remain the most studied regimen for cycle regulation in PCOS. The ACOG Technical Bulletin specifies that COCs reduce LH excess, suppress androgens, and provide endometrial protection against hyperplasia from unopposed estrogen. For women who prefer not to use estrogen, progestin-only withdrawal bleeds (medroxyprogesterone acetate 10 mg for 10 to 14 days per cycle) protect the endometrium while the underlying metabolic issue is addressed.

Weight loss of 5 to 10% of body weight in women with PCOS and BMI above 27 kg/m² can restore spontaneous ovulation. A 2019 Cochrane review (21 RCTs, N=1,451) found lifestyle intervention restored ovulatory cycles in 46% of participants without any pharmacologic treatment.

Treating Hypothalamic Amenorrhea

The Endocrine Society guideline states: "Cognitive behavioral therapy should be offered to women with functional hypothalamic amenorrhea to address the psychological contributors to energy deficiency." Increasing caloric intake to restore energy availability above 45 kcal per kg of fat-free mass per day typically produces a return of menses within three to six months. HRT or the pill may be added to protect bone while recovery occurs, but they do not restore the underlying HPO axis function on their own.

Prolactinoma Management

Cabergoline 0.5 mg twice weekly normalizes prolactin in 85 to 90% of patients and shrinks tumor volume by more than 50% in the majority. A landmark study in the New England Journal of Medicine (N=459) comparing cabergoline to bromocriptine found cabergoline restored ovulatory cycles in 72% vs. 52% of women at 24 weeks (P<0.001). Periods typically resume within two to three months of achieving normal prolactin levels.

Hormone Replacement Therapy for POI

Women with POI need systemic HRT (or combined oral contraceptives as an alternative) until at least age 51. Transdermal estradiol 100 mcg/day combined with cyclic micronized progesterone 200 mg for 12 days per month is the regimen supported by the ESHRE 2016 guideline. This approach restores menstrual cycling, maintains bone mineral density, and reduces cardiovascular risk compared with untreated POI.

Anatomic Causes

Surgical correction of an imperforate hymen, vaginal septum, or cervical stenosis is straightforward and typically curative. Asherman syndrome treatment with hysteroscopic adhesiolysis restores normal menstrual flow in 70 to 90% of mild-to-moderate cases, though severe disease may require multiple procedures.

Lifestyle Factors That Affect Cycle Regularity

Cycle disruption does not always indicate disease. Recognizing modifiable contributors can speed recovery.

Body Weight and Energy Intake

Both low body weight (BMI <18.5 kg/m²) and rapid weight loss suppress the HPO axis. The brain reads a caloric deficit as famine and shuts down reproduction as a survival response. Conversely, obesity-driven insulin resistance raises insulin and IGF-1, which amplify ovarian androgen production and contribute to PCOS-related anovulation.

Exercise Volume

Female athletes training more than 10 hours per week, particularly in endurance or aesthetic sports, have substantially higher rates of HA. The Female Athlete Triad (low energy availability, low bone density, menstrual dysfunction) remains a recognized clinical syndrome. A 2014 position statement from the American College of Sports Medicine recommends energy availability screening for any athlete missing two or more consecutive periods.

Psychological Stress

Cortisol and CRH directly inhibit GnRH pulsatility. Severe acute stress (bereavement, major illness, trauma) can suppress ovulation for one to three cycles. Chronic stress has a more sustained effect. When stress is the only identifiable cause, cycles usually return within one to three months after the stressor resolves, without any hormonal treatment.

Medications That Disrupt Cycles

Several commonly used drugs alter cycle regularity:

• Antipsychotics (risperidone, haloperidol): raise prolactin above 60 ng/mL in up to 40% of users, suppressing ovulation
• Depot medroxyprogesterone acetate (Depo-Provera): causes amenorrhea in 50% of users by 12 months; cycle return after discontinuation may take 6 to 12 months
• Levonorgestrel IUD: reduces menstrual flow by 90% at 12 months; complete amenorrhea occurs in 20% of users and is expected, not pathologic
• GnRH agonists (leuprolide for endometriosis): intentionally induce medical menopause; cycles return 1 to 3 months after the last depot injection
• Opioids: chronic opioid use suppresses LH pulsatility and causes hypogonadotropic hypogonadism in up to 30% of female users

Tell your prescribing clinician about every medication, supplement, and herbal product before attributing amenorrhea to an unknown cause.

Special Populations

Adolescents

Cycles are normally irregular for the first two years after menarche. Missing one to two periods in the first year is expected. However, any adolescent who has not started menstruation by age 15 with otherwise normal puberty needs a referral to a pediatric endocrinologist or gynecologist. Delaying evaluation beyond age 16 can miss conditions requiring time-sensitive treatment (anatomic obstruction, Turner syndrome).

Perimenopause

Women aged 40 to 51 who begin missing periods may be entering the menopausal transition. FSH above 10 IU/L drawn on cycle day 3, combined with irregular cycles, supports this. Perimenopause does not mean infertility: ovulation can still occur in irregular cycles, and contraception remains necessary until 12 consecutive months of amenorrhea confirm menopause. POI must still be excluded in women under 45 with rising FSH.

Women Using GLP-1 Medications

Anecdotal reports suggest that rapid weight loss with semaglutide (Ozempic, Wegovy) or tirzepatide can alter cycle regularity, either restoring cycles in women with obesity-related PCOS or, less commonly, causing transient cycle lengthening during rapid caloric restriction. A 2023 survey-based study in Frontiers in Endocrinology found 66% of women with PCOS reported improved cycle regularity after 6 months of GLP-1 receptor agonist treatment. The mechanism is likely weight-loss-mediated reduction in insulin and androgen levels, not a direct drug effect on the HPO axis.